Companies ›Healthcare ›CBL.AX

CBL.AX — ASX Advanced Medical Equipment & Technology

Cbl.Ax

A$0,09

Open in Charts → Attach watcher ⌖

— —

AUD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

-84,2 %

ROE

-110,9 %

Net margin

-86,8 %

Debt / equity

0,08

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

CBL.AX operates in the healthcare equipment sector, providing medical devices and related technologies to support clinical and diagnostic applications.

Business. CBL & Associates Properties Inc. is an equity real estate investment trust that generates revenue primarily through rental income. The company is headquartered in the United States and is listed on the New York Stock Exchange under the ticker symbol CBL. Specific details regarding its operating segments and geographic mix are not provided in the available data.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

ActivityHealthcare Equipment

Generated · model-assisted

Sell-side consensus

BUY1 analysts

1 buy0 hold0 sell

Avg 12m price target50,00

Analyst recommendations

1 analysts · consensus Buy

Buy1

Hold0

Sell0

12-month price target

50,00

Consensus of sell-side coverage.

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

1 analysts · indicative

Ownership→

Arrowstreet Capital, Limited Partnership

largest disclosed fund holder

Profitability→

-110,9 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning CBL.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to CBL.AX. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

CBL & Associates Properties Inc. is an equity real estate investment trust that generates revenue primarily through rental income. The company is headquartered in the United States and is listed on the New York Stock Exchange under the ticker symbol CBL. Specific details regarding its operating segments and geographic mix are not provided in the available data.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

ActivityHealthcare Equipment

AI synthesis

GENERATED

CBL.AX exhibits a capital structure with a low debt-to-equity ratio of 0.08, indicating a conservative leverage profile. However, the company's liquidity position is rated as medium, with a current ratio of 1.24, suggesting limited short-term liquidity cushion. Free cash flow is negative at -5.56 million AUD, and operating cash flow is also negative at -4.27 million AUD, signaling cash flow constraints.

Profitability metrics are sharply negative, with a return on equity of -110.89% and a return on assets of -74.2%. These figures fall well below the typical performance benchmarks for the Advanced Medical Equipment & Technology industry, which usually expects positive returns on invested capital. The company reported a net loss of 6.11 million AUD and an operating loss of 5.93 million AUD, reflecting significant operational challenges.

Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration is likely within its core healthcare equipment business. No specific geographic breakdown is provided, and the absence of disclosed segments limits visibility into diversification or concentration risks.

Growth trajectory is currently negative, with the company reporting a revenue of 70.40 million AUD. Without forward-looking guidance or historical revenue growth data, it is difficult to assess the company's long-term growth potential. The negative operating and net income suggest a lack of momentum in scaling operations or improving margins.

Risk factors include liquidity constraints and the absence of positive cash flow generation. The company's dilution risk is rated as low, with no significant dilution potential identified in the basic shares outstanding. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to fund operations without external financing.

Recent events or filings are not detailed in the available data, but the company's financial performance in the latest period indicates a need for strategic or operational adjustments to restore profitability and cash flow generation.

Key takeaways

CBL.AX is operating at a significant loss, with negative returns on equity and assets.
The company's liquidity position is weak, with a current ratio of 1.24 and negative free cash flow.
Debt levels are low, but the negative net cash position raises concerns about financial flexibility.
No clear growth trajectory is evident from the latest financial data.
The company's risk profile is dominated by liquidity and operational performance risks.

Bull / Bear case

Generated · model-assisted

BULL CASE · 3

The company's 10.84% net margin significantly outperforms the 0.06% median for Real Estate Investment Trusts.

Cash conversion of 1.14 exceeds the 0.57 median for the Real Estate Investment Trusts cohort.

Analysts assign a strong buy rating with a $50 target, implying 3.2% upside from $48.47.

BEAR CASE · 3

A debt-to-equity ratio of 5.28 ranks in the bottom quartile compared to REIT peers.

The company faces a medium level of liquidity risk according to current risk flag assessments.

Revenue experienced a negative 0.8% CAGR over the two-year period from FY2023 to FY2025.

In focus — financials by report

Valuation

Market price

A$0,09

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

A$5.5M

Net cashⓘ

-A$435.4k

Current ratioⓘ

1.2

Debt / equityⓘ

0.1

ROAⓘ

-74.2%

ROEⓘ

-1.1%

Cash conversionⓘ

70.0%

CapEx / revenueⓘ

-6.3%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%